ABBOTT FDA Approval ANDA 063265

ANDA 063265

ABBOTT

FDA Drug Application

Application #063265

Application Sponsors

ANDA 063265ABBOTT

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 250MG BASE/ML0AMIKACIN SULFATEAMIKACIN SULFATE

FDA Submissions

ORIG1AP1994-11-30

CDER Filings

ABBOTT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 63265
            [companyName] => ABBOTT
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMIKACIN SULFATE","activeIngredients":"AMIKACIN SULFATE","strength":"EQ 250MG BASE\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AMIKACIN SULFATE","submission":"AMIKACIN SULFATE","actionType":"EQ 250MG BASE\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.